Royalty aggregators like Royalty Pharma, Ligand, and XOMA are revolutionizing biotech by providing upfront cash for R&D. Read ...
Researchers developed a method to assess the ability of small molecules to bind to hundreds of human proteins using AI and ML ...
Blueprint Medicines Corporation BPMC reported first-quarter 2024 adjusted loss of $1.32 per share, narrower than the Zacks ...
Discover Ligand Pharmaceuticals Inc's groundbreaking patent for compounds treating leukemia and hematopoietic disorders. Explore the versatile pharmaceutical compositions and potential applications ...
Tumor cells are "cunning," according to Peter Yingxiao Wang. They have a nefarious way of evading the human immune responses ...
The CEO of a new company pushing a Novan developed drug toward commercialization says things will be different this time. A new biopharmaceutical company is picking up where a Durham-based firm ...
Cite this: Osteoprotegerin and its Ligand: A New Paradigm for Regulation of Osteoclastogenesis and Bone Resorption - Medscape - Mar 08, 2000. Dr. Aubin is Professor and Chair, Department of ...
PRESS RELEASECHARM Therapeutics appoints Dr Nicholas Edmunds as Chief Development Officer, Head of Pre-Clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback